Amerise Biosciences Balance Sheet Health
Financial Health criteria checks 2/6
Amerise Biosciences has a total shareholder equity of ₹54.2M and total debt of ₹1.3M, which brings its debt-to-equity ratio to 2.4%. Its total assets and total liabilities are ₹55.6M and ₹1.4M respectively.
Key information
2.4%
Debt to equity ratio
₹1.30m
Debt
Interest coverage ratio | n/a |
Cash | ₹357.00k |
Equity | ₹54.15m |
Total liabilities | ₹1.44m |
Total assets | ₹55.59m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 531681's short term assets (₹357.0K) exceed its short term liabilities (₹140.0K).
Long Term Liabilities: 531681's short term assets (₹357.0K) do not cover its long term liabilities (₹1.3M).
Debt to Equity History and Analysis
Debt Level: 531681's net debt to equity ratio (1.7%) is considered satisfactory.
Reducing Debt: 531681's debt to equity ratio has increased from 0% to 2.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 531681 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 531681 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15.7% each year